Examining Opioid Treatment Infrastructure Act of 2016

Bill: 114-hr-4982
Sponsor: full_name: Rep. Foster, Bill [D-IL-11]
Introduced: 2016-04-18
Policy area: Health
Subjects: Alaska Natives and Hawaiians

Child health

Congressional oversight

Drug therapy

Drug trafficking and controlled substances

Drug, alcohol, tobacco use

Government studies and investigations

Health information and medical records

Home and outpatient care

Hospital care

Indian social and development programs

Minority health

Women's health
Latest action: action_date: 2016-05-12
text: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Summaries:
action_date: 2016-04-18
action_desc: Introduced in House
text: <p><b>Examining Opioid Treatment Infrastructure Act of 2016</b></p> This bill requires the Government Accountability Office to report on inpatient and outpatient treatment capacity, availability, and needs, including detoxification programs, clinical stabilization programs, transitional residential support services, rehabilitation programs, and treatment programs for pregnant women or adolescents.

action_date: 2016-05-10
action_desc: Reported to House with amendment(s)
text: <p><b>Examining Opioid Treatment Infrastructure Act of 2016</b></p> <p>(Sec. 2) This bill requires the Government Accountability Office to report on inpatient and outpatient treatment capacity, availability, and needs, including detoxification programs, clinical stabilization programs, transitional residential support services, rehabilitation programs, treatment programs for pregnant women or adolescents, and treatment through Indian health programs. The report must include the barriers to real-time reporting of drug overdoses at the federal, state, and local level and ways to overcome those barriers.</p>

action_date: 2016-05-11
action_desc: Passed House amended
text: <p>(This measure has not been amended since it was reported to the House on May 10, 2016. The summary of that version is repeated here.)</p> <p><b>Examining Opioid Treatment Infrastructure Act of 2016</b></p> <p>(Sec. 2) This bill requires the Government Accountability Office to report on inpatient and outpatient treatment capacity, availability, and needs, including detoxification programs, clinical stabilization programs, transitional residential support services, rehabilitation programs, treatment programs for pregnant women or adolescents, and treatment through Indian health programs. The report must include the barriers to real-time reporting of drug overdoses at the federal, state, and local level and ways to overcome those barriers.</p>

tv_txt: I 114th CONGRESS 2d Session H. R. 4982 IN THE HOUSE OF REPRESENTATIVES April 18, 2016 Mr. Foster (for himself and Mr. Pallone ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To direct the Comptroller General of the United States to evaluate and report on the in-patient and outpatient treatment capacity, availability, and needs of the United States.

1. Short title This Act may be cited as the Examining Opioid Treatment Infrastructure Act of 2016 . 2. Study on treatment infrastructure Not later than 24 months after the date of enactment of this Act, the Comptroller General of the United States shall initiate an evaluation, and submit to Congress a report, of the in-patient and outpatient treatment capacity, availability, and needs of the United States, which shall include, to the extent data is available— (1) the capacity of acute residential or inpatient detoxification programs; (2) the capacity of inpatient clinical stabilization programs, transitional residential support services, and residential rehabilitation programs; (3) the capacity of demographic specific residential or inpatient treatment programs, such as those designed for pregnant women or adolescents; (4) geographical differences of the availability of residential and outpatient treatment and recovery options for substance use disorders across the continuum of care; (5) the availability of residential and outpatient treatment programs that offer treatment options based on reliable scientific evidence of efficacy for the treatment of substance use disorders, including the use of Food and Drug Administration-approved medicines and evidence-based nonpharmacological therapies; (6) the number of patients in residential and specialty outpatient treatment services for substance use disorders; and (7) an assessment of the need for residential and outpatient treatment for substance use disorders across the continuum of care.

tv_txt: IB 114th CONGRESS 2d Session H. R. 4982 IN THE HOUSE OF REPRESENTATIVES AN ACT To direct the Comptroller General of the United States to evaluate and report on the in-patient and outpatient treatment capacity, availability, and needs of the United States.

1. Short title This Act may be cited as the Examining Opioid Treatment Infrastructure Act of 2016 . 2. Study on treatment infrastructure Not later than 24 months after the date of enactment of this Act, the Comptroller General of the United States shall initiate an evaluation, and submit to Congress a report, of the inpatient and outpatient treatment capacity, availability, and needs of the United States, which shall include, to the extent data are available— (1) the capacity of acute residential or inpatient detoxification programs; (2) the capacity of inpatient clinical stabilization programs, transitional residential support services, and residential rehabilitation programs; (3) the capacity of demographic specific residential or inpatient treatment programs, such as those designed for pregnant women or adolescents; (4) geographical differences of the availability of residential and outpatient treatment and recovery options for substance use disorders across the continuum of care; (5) the availability of residential and outpatient treatment programs that offer treatment options based on reliable scientific evidence of efficacy for the treatment of substance use disorders, including the use of Food and Drug Administration-approved medicines and evidence-based nonpharmacological therapies; (6) the number of patients in residential and specialty outpatient treatment services for substance use disorders; (7) an assessment of the need for residential and outpatient treatment for substance use disorders across the continuum of care; (8) the availability of residential and outpatient treatment programs to American Indians and Alaska Natives through an Indian health program (as defined by section 4 of the Indian Health Care Improvement Act ( 25 U.S.C. 1603 )); and (9) the barriers (including technological barriers) at the Federal, State, and local levels to real-time reporting of de-identified information on drug overdoses and ways to overcome such barriers.

Passed the House of Representatives May 11, 2016. Karen L. Haas, Clerk.

tv_txt: IB Union Calendar No. 434 114th CONGRESS 2d Session H. R. 4982 [Report No. 114–560] IN THE HOUSE OF REPRESENTATIVES April 18, 2016 Mr. Foster (for himself and Mr. Pallone ) introduced the following bill; which was referred to the Committee on Energy and Commerce May 10, 2016 Additional sponsors: Ms. Herrera Beutler , Mr. Rokita , Mr. Kilmer , and Mr. Turner May 10, 2016 Reported with an amendment, committed to the Committee of the Whole House on the State of the Union, and ordered to be printed Strike out all after the enacting clause and insert the part printed in italic For text of introduced bill, see copy of bill as introduced on April 18, 2016 A BILL To direct the Comptroller General of the United States to evaluate and report on the in-patient and outpatient treatment capacity, availability, and needs of the United States.

1. Short title This Act may be cited as the Examining Opioid Treatment Infrastructure Act of 2016 . 2. Study on treatment infrastructure Not later than 24 months after the date of enactment of this Act, the Comptroller General of the United States shall initiate an evaluation, and submit to Congress a report, of the inpatient and outpatient treatment capacity, availability, and needs of the United States, which shall include, to the extent data are available— (1) the capacity of acute residential or inpatient detoxification programs; (2) the capacity of inpatient clinical stabilization programs, transitional residential support services, and residential rehabilitation programs; (3) the capacity of demographic specific residential or inpatient treatment programs, such as those designed for pregnant women or adolescents; (4) geographical differences of the availability of residential and outpatient treatment and recovery options for substance use disorders across the continuum of care; (5) the availability of residential and outpatient treatment programs that offer treatment options based on reliable scientific evidence of efficacy for the treatment of substance use disorders, including the use of Food and Drug Administration-approved medicines and evidence-based nonpharmacological therapies; (6) the number of patients in residential and specialty outpatient treatment services for substance use disorders; (7) an assessment of the need for residential and outpatient treatment for substance use disorders across the continuum of care; (8) the availability of residential and outpatient treatment programs to American Indians and Alaska Natives through an Indian health program (as defined by section 4 of the Indian Health Care Improvement Act ( 25 U.S.C. 1603 )); and (9) the barriers (including technological barriers) at the Federal, State, and local levels to real-time reporting of de-identified information on drug overdoses and ways to overcome such barriers.

May 10, 2016 Reported with an amendment, committed to the Committee of the Whole House on the State of the Union, and ordered to be printed

tv_txt: IIB 114th CONGRESS 2d Session H. R. 4982 IN THE SENATE OF THE UNITED STATES May 12, 2016 Received; read twice and referred to the Committee on Health, Education, Labor, and Pensions AN ACT To direct the Comptroller General of the United States to evaluate and report on the in-patient and outpatient treatment capacity, availability, and needs of the United States.

1. Short title This Act may be cited as the Examining Opioid Treatment Infrastructure Act of 2016 . 2. Study on treatment infrastructure Not later than 24 months after the date of enactment of this Act, the Comptroller General of the United States shall initiate an evaluation, and submit to Congress a report, of the inpatient and outpatient treatment capacity, availability, and needs of the United States, which shall include, to the extent data are available— (1) the capacity of acute residential or inpatient detoxification programs; (2) the capacity of inpatient clinical stabilization programs, transitional residential support services, and residential rehabilitation programs; (3) the capacity of demographic specific residential or inpatient treatment programs, such as those designed for pregnant women or adolescents; (4) geographical differences of the availability of residential and outpatient treatment and recovery options for substance use disorders across the continuum of care; (5) the availability of residential and outpatient treatment programs that offer treatment options based on reliable scientific evidence of efficacy for the treatment of substance use disorders, including the use of Food and Drug Administration-approved medicines and evidence-based nonpharmacological therapies; (6) the number of patients in residential and specialty outpatient treatment services for substance use disorders; (7) an assessment of the need for residential and outpatient treatment for substance use disorders across the continuum of care; (8) the availability of residential and outpatient treatment programs to American Indians and Alaska Natives through an Indian health program (as defined by section 4 of the Indian Health Care Improvement Act ( 25 U.S.C. 1603 )); and (9) the barriers (including technological barriers) at the Federal, State, and local levels to real-time reporting of de-identified information on drug overdoses and ways to overcome such barriers.

Passed the House of Representatives May 11, 2016. Karen L. Haas, Clerk